CClinicalTrials.gg
CompletedNCT05488652Updated Aug 17, 2026Results posted

Cerebromicrovascular Effects of Time-Restricted Eating in Older Adults

An interventional study of Time restricted eating in Time Restricted Eating, sponsored by University of Oklahoma. Completed at 1 site in United States. Open to participants aged 21 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-17.

Sponsored by University of Oklahoma · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
11
Allocation
Not applicable
Ages
21 Years and older
Sex
All
01

Study summary

The central hypothesis of this study is that closer adherence to time restricted eating (TRE) will improve endothelial function, neurovascular (NVC) responses, resulting in improved cognitive performance, potentially through activation of SIRT1-dependent vasoprotective pathways.

Read the detailed description

This hypothesis will be tested by assessing the effect of TRE (not more than 10hr eating window each day for 6 months) in healthy adults (≥21 years of age).

02

Conditions studied

  • Time Restricted Eating

Browse trials for

Keywords

  • Time restricted eating
  • Intermittent fasting
  • neurovascular coupling
  • cognitive function
  • aging
03

In context

Intermittent Fasting

148 studies on the registry are indexed under Intermittent Fasting; 68 are open to participants now.

This study's enrollment of 11 is below the median of 60 across 144 interventional studies indexed under Intermittent Fasting.

Browse Intermittent Fasting studies →

Lead sponsor

University of Oklahoma is the lead sponsor of 424 studies on the registry; 99 are open to participants now.

Of its 42 completed or terminated interventional studies of FDA-regulated products, 16 (38%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Age ≥21 years
  • Adequate hearing and visual acuity to participate in examinations
  • Ability to read and write in English
  • Competence to provide informed consent

Exclusion criteria

Exclusion Criteria:

  • Vision or hearing impairment that would impair the ability to complete study assessments
  • Active CNS disease including multiple sclerosis, uncontrolled seizures, and active brain cancer
  • Cerebrovascular accident other than TIA within 60 days prior to screening
  • Any other medical condition which, in the opinion of the investigator, would render the participant inappropriate or too unstable to complete the study protocol
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
11 participants (actual)

Study arms

  • Experimental
    Time restricted eating

    14 h of fasting daily (10 h of free eating)

    Behavioral: Time restricted eating

Interventions

  • BehavioralTime restricted eating

    14:10 daily fasting regimen

06

What researchers measure

Primary outcomes

  1. Neurovascular Coupling Using Functional Near Infrared Spectroscopy (fNIRS)

    Functional near infrared spectroscopy (fNIRS) will be performed during the cognitive n-back task. fNIRS approach generates data that represent a relative change in oxygenated hemoglobin measured over the cortical brain tissues. fNIRS data is analyzed using a pipeline based on the General Linear Model (GLM) approach created using the Brain AnalyzIR toolbox and implemented in MatLab. At the subject level, regression coefficients (beta values) are extracted to characterize individual neurovascular coupling response in the prefrontal cortex across all n-back blocks. It is expected that more difficult cognitive tasks will lead to increased neurovascular coupling responses in healthy individuals, but no clinically relevant ranges exist for this measure.

    Time frame: Baseline, 6 months

Secondary outcomes

  1. Neurovascular Coupling Using the Dynamic Retinal Vessel Analysis

    Flicker light-induced dilation of the retinal vessels (percentage increase over baseline diameter) will be measured in the right or left eye of each study participant using the Dynamic Vessel Analyzer (DVA, IMEDOS Systems, Jena, Germany). The change in retinal vessel diameters is tracked and reported as a %change from baseline, before and after treatment.

    Time frame: Baseline, 6 months

  2. Neurovascular Coupling Using Transcranial Doppler

    Transcranial Doppler sonography will be used to measure the change in the blood flow velocities during the cognitive n-back task between before and after treatment.

    Time frame: Baseline, 6 months

  3. Microvascular Endothelial Function

    Changes in microvascular endothelial function will be assessed using laser speckle contrast imaging (LSCI) in the hand using the flow mediated dilation approach. The change in skin perfusion is calculated and reported as a fold change from baseline.

    Time frame: Baseline, 6 months

  4. Macrovascular Endothelial Function

    Changes in macrovascular endothelial function will be assessed using sonography during flow mediated dilation approach. The change in brachial artery diameter is calculated and reported as a %change from baseline.

    Time frame: Baseline, 6 months

  5. Deep Tissue Oxygen Saturation

    Transcutaneous deep tissue oxygen saturation will be measured using the inSpectra near infrared device. The data are calculated and reported as a %change from baseline.

    Time frame: Baseline, 6 months

  6. Arterial Stiffness

    The arterial stiffness will be measured using the pulse wave analysis approach (SphygmoCor, Atcor medical, Itasca IL, or similar). Analysis generated the augmentation index which will be used for comparison before and after treatment.

    Time frame: Baseline, 6 months

  7. ECG

    ECG will be recorded for heart rate variability analysis. The values of high frequency domain, low frequency domain, their ratio, as well as total power will be calculated and used for comparison before and after treatment.

    Time frame: Baseline, 6 months

  8. Glycocalyx - Perfused Boundary Region

    Video recordings of the sublingual vasculature will be performed using the high definition video camera GlycoCheck (Microvascular health solutions). Data collected will include perfused boundary region (um), and will be used for comparison before and after treatment.

    Time frame: Baseline, 6 months

  9. Capillary Density

    Video recordings of the sublingual vasculature will be performed using the high definition video camera GlycoCheck (Microvascular health solutions). Data collected will include capillary density (mm/mm\^2), and will be used for comparison before and after treatment.

    Time frame: Baseline, 6 months

  10. Red Blood Cell Velocity

    Video recordings of the sublingual vasculature will be performed using the high definition video camera GlycoCheck (Microvascular health solutions). Data collected will include red blood cell velocity (um/sec), and will be used for comparison before and after treatment.

    Time frame: Baseline, 6 months

  11. Inhibitory Control and Attention

    Flanker Inhibitory Control and Attention Test was used to assess inhibitory control and attention. The participant is asked to focus on a particular stimulus while inhibiting attention to the stimuli flanking it. Scores are fully adjusted to nationally representative normative sample of NIH toolbox test takers, accounting for age, sex, race, and education (mean = 50; SD = 10). Higher scores represent better outcomes.

    Time frame: Baseline, 6 months

  12. Episodic Memory

    Picture Sequence Memory Test was used to assess episodic memory. Participants are shown a number of activities, and then asked to reproduce the sequence of pictures as it was presented to them. Scores are fully adjusted to nationally representative normative sample of NIH toolbox test takers, accounting for age, sex, race, and education (mean = 50; SD = 10). Higher scores represent better outcomes.

    Time frame: Baseline, 6 months

  13. Working Memory

    List Sorting Working Memory Test was used to assess working memory. The participant is asked to recall and sequence different stimuli that are presented visually and via audio. Scores are fully adjusted to nationally representative normative sample of NIH toolbox test takers, accounting for age, sex, race, and education (mean = 50; SD = 10). Higher scores represent better outcomes.

    Time frame: Baseline, 6 months

  14. Language

    Picture Vocabulary Test measures receptive vocabulary administered in a computer-adaptive test (CAT) format. Respondents select the picture that most closely matches the meaning of the word. Scores are fully adjusted to nationally representative normative sample of NIH toolbox test takers, accounting for age, sex, race, and education (mean = 50; SD = 10). Higher scores represent better outcomes.

    Time frame: Baseline, 6 months

  15. Executive Function

    Dimensional Change Card Sort Test was used to assess cognitive flexibility and attention. The participant is asked to match a series of picture pairs to a target picture. Scores are fully adjusted to nationally representative normative sample of NIH toolbox test takers, accounting for age, sex, race, and education (mean = 50; SD = 10). Higher scores represent better outcomes.

    Time frame: Baseline, 6 months

  16. Processing Speed

    Pattern Comparison Processing Speed Test was used to assess processing speed. Participants are asked to quickly determine whether two stimuli are the same or not the same. Scores are fully adjusted to nationally representative normative sample of NIH toolbox test takers, accounting for age, sex, race, and education (mean = 50; SD = 10). Higher scores represent better outcomes.

    Time frame: Baseline, 6 months

07

Results

Posted Aug 17, 2026
Limitations and caveats
Study limitations include: * Small sample size * High dropout rate * No male sex representation

Participant flow

Participant flow — Overall Study
MilestoneTime Restricted Eating
Started11
Completed6
Not completed5
Withdrew: Withdrawal by subject4
Withdrew: Lost to follow-up1

Outcome measures

PrimaryNeurovascular Coupling Using Functional Near Infrared Spectroscopy (fNIRS)

Functional near infrared spectroscopy (fNIRS) will be performed during the cognitive n-back task. fNIRS approach generates data that represent a relative change in oxygenated hemoglobin measured over the cortical brain tissues. fNIRS data is analyzed using a pipeline based on the General Linear Model (GLM) approach created using the Brain AnalyzIR toolbox and implemented in MatLab. At the subject level, regression coefficients (beta values) are extracted to characterize individual neurovascular coupling response in the prefrontal cortex across all n-back blocks. It is expected that more difficult cognitive tasks will lead to increased neurovascular coupling responses in healthy individuals, but no clinically relevant ranges exist for this measure.

Time frame:
Baseline, 6 months
Reported as:
Mean · Beta value
Neurovascular Coupling Using Functional Near Infrared Spectroscopy (fNIRS)
Beta valueBaselineEndpoint
Neurovascular Coupling Using Functional Near Infrared Spectroscopy (fNIRS)-4.6 ± 4.932.3 ± 44.9
SecondaryNeurovascular Coupling Using the Dynamic Retinal Vessel Analysis

Flicker light-induced dilation of the retinal vessels (percentage increase over baseline diameter) will be measured in the right or left eye of each study participant using the Dynamic Vessel Analyzer (DVA, IMEDOS Systems, Jena, Germany). The change in retinal vessel diameters is tracked and reported as a %change from baseline, before and after treatment.

Time frame:
Baseline, 6 months

No measurements were reported for this outcome.

SecondaryNeurovascular Coupling Using Transcranial Doppler

Transcranial Doppler sonography will be used to measure the change in the blood flow velocities during the cognitive n-back task between before and after treatment.

Time frame:
Baseline, 6 months

No measurements were reported for this outcome.

SecondaryMicrovascular Endothelial Function

Changes in microvascular endothelial function will be assessed using laser speckle contrast imaging (LSCI) in the hand using the flow mediated dilation approach. The change in skin perfusion is calculated and reported as a fold change from baseline.

Time frame:
Baseline, 6 months
Reported as:
Mean · fold change from baseline
Microvascular Endothelial Function
fold change from baselineBaselineEndpoint
Microvascular Endothelial Function3.36 (1.83 to 4.03)3.19 (1.68 to 5.62)
Statistical analysis
  • Baseline vs Endpoint · Wilcoxon (Mann-Whitney) · p = 0.8125 (Two-tailed exact P value)Paired samples
SecondaryMacrovascular Endothelial Function

Changes in macrovascular endothelial function will be assessed using sonography during flow mediated dilation approach. The change in brachial artery diameter is calculated and reported as a %change from baseline.

Time frame:
Baseline, 6 months
Reported as:
Mean · %change from baseline
Macrovascular Endothelial Function
%change from baselineBaselineEndpoint
Macrovascular Endothelial Function8.20 (4.15 to 15.02)4.96 (2.61 to 9.91)
Statistical analysis
  • Baseline vs Endpoint · Wilcoxon (Mann-Whitney) · p = 0.6250 (Two-tailed exact P-value)Paired samples
SecondaryDeep Tissue Oxygen Saturation

Transcutaneous deep tissue oxygen saturation will be measured using the inSpectra near infrared device. The data are calculated and reported as a %change from baseline.

Time frame:
Baseline, 6 months

No measurements were reported for this outcome.

SecondaryArterial Stiffness

The arterial stiffness will be measured using the pulse wave analysis approach (SphygmoCor, Atcor medical, Itasca IL, or similar). Analysis generated the augmentation index which will be used for comparison before and after treatment.

Time frame:
Baseline, 6 months

No measurements were reported for this outcome.

SecondaryECG

ECG will be recorded for heart rate variability analysis. The values of high frequency domain, low frequency domain, their ratio, as well as total power will be calculated and used for comparison before and after treatment.

Time frame:
Baseline, 6 months

No measurements were reported for this outcome.

SecondaryGlycocalyx - Perfused Boundary Region

Video recordings of the sublingual vasculature will be performed using the high definition video camera GlycoCheck (Microvascular health solutions). Data collected will include perfused boundary region (um), and will be used for comparison before and after treatment.

Time frame:
Baseline, 6 months

No measurements were reported for this outcome.

SecondaryCapillary Density

Video recordings of the sublingual vasculature will be performed using the high definition video camera GlycoCheck (Microvascular health solutions). Data collected will include capillary density (mm/mm\^2), and will be used for comparison before and after treatment.

Time frame:
Baseline, 6 months

No measurements were reported for this outcome.

SecondaryRed Blood Cell Velocity

Video recordings of the sublingual vasculature will be performed using the high definition video camera GlycoCheck (Microvascular health solutions). Data collected will include red blood cell velocity (um/sec), and will be used for comparison before and after treatment.

Time frame:
Baseline, 6 months

No measurements were reported for this outcome.

SecondaryInhibitory Control and Attention

Flanker Inhibitory Control and Attention Test was used to assess inhibitory control and attention. The participant is asked to focus on a particular stimulus while inhibiting attention to the stimuli flanking it. Scores are fully adjusted to nationally representative normative sample of NIH toolbox test takers, accounting for age, sex, race, and education (mean = 50; SD = 10). Higher scores represent better outcomes.

Time frame:
Baseline, 6 months
Reported as:
Mean · T score
Inhibitory Control and Attention
T scoreBaselineEndpoint
Inhibitory Control and Attention44 (36 to 61)50 (42 to 57)
Statistical analysis
  • Baseline vs Endpoint · Wilcoxon (Mann-Whitney) · p = 0.2188 (Two-tailed exact P-value)Paired samples
SecondaryEpisodic Memory

Picture Sequence Memory Test was used to assess episodic memory. Participants are shown a number of activities, and then asked to reproduce the sequence of pictures as it was presented to them. Scores are fully adjusted to nationally representative normative sample of NIH toolbox test takers, accounting for age, sex, race, and education (mean = 50; SD = 10). Higher scores represent better outcomes.

Time frame:
Baseline, 6 months
Reported as:
Mean · T score
Episodic Memory
T scoreBaselineEndpoint
Episodic Memory56 (49 to 63)54 (45 to 58)
Statistical analysis
  • Baseline vs Endpoint · Wilcoxon (Mann-Whitney) · p = 0.8125 (Two-tailed exact P-value)Paired samples
SecondaryWorking Memory

List Sorting Working Memory Test was used to assess working memory. The participant is asked to recall and sequence different stimuli that are presented visually and via audio. Scores are fully adjusted to nationally representative normative sample of NIH toolbox test takers, accounting for age, sex, race, and education (mean = 50; SD = 10). Higher scores represent better outcomes.

Time frame:
Baseline, 6 months
Reported as:
Mean · T score
Working Memory
T scoreBaselineEndpoint
Working Memory55 (33 to 66)51 (40 to 70)
Statistical analysis
  • Baseline vs Endpoint · Wilcoxon (Mann-Whitney) · p = 0.8125 (Two-tailed exact P-value)Paired samples
SecondaryLanguage

Picture Vocabulary Test measures receptive vocabulary administered in a computer-adaptive test (CAT) format. Respondents select the picture that most closely matches the meaning of the word. Scores are fully adjusted to nationally representative normative sample of NIH toolbox test takers, accounting for age, sex, race, and education (mean = 50; SD = 10). Higher scores represent better outcomes.

Time frame:
Baseline, 6 months
Reported as:
Mean · T score
Language
T scoreBaselineEndpoint
Language51 (44 to 63)51 (33 to 60)
Statistical analysis
  • Baseline vs Endpoint · Wilcoxon (Mann-Whitney) · p = >0.9999 (Two-tailed exact P-value)Paired samples
SecondaryExecutive Function

Dimensional Change Card Sort Test was used to assess cognitive flexibility and attention. The participant is asked to match a series of picture pairs to a target picture. Scores are fully adjusted to nationally representative normative sample of NIH toolbox test takers, accounting for age, sex, race, and education (mean = 50; SD = 10). Higher scores represent better outcomes.

Time frame:
Baseline, 6 months
Reported as:
Mean · T score
Executive Function
T scoreBaselineEndpoint
Executive Function63 (45 to 75)65 (45 to 81)
Statistical analysis
  • Baseline vs Endpoint · Wilcoxon (Mann-Whitney) · p = 0.5000 (Two-tailed exact P-value)Paired samples
SecondaryProcessing Speed

Pattern Comparison Processing Speed Test was used to assess processing speed. Participants are asked to quickly determine whether two stimuli are the same or not the same. Scores are fully adjusted to nationally representative normative sample of NIH toolbox test takers, accounting for age, sex, race, and education (mean = 50; SD = 10). Higher scores represent better outcomes.

Time frame:
Baseline, 6 months
Reported as:
Mean · T score
Processing Speed
T scoreBaselineEndpoint
Processing Speed53 (42 to 78)58 (44 to 72)
Statistical analysis
  • Baseline vs Endpoint · Wilcoxon (Mann-Whitney) · p = 0.6250 (Two-tailed exact P-value)Paired samples

Adverse events

Collected over From enrollment to 6 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Intervention0/11 (0%)0/11 (0%)0/11 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Time Restricted Eating
<=18 years0
Between 18 and 65 years10
>=65 years1
Sex: Female, Male
Sex: Female, Male(Participants)Time Restricted Eating
Female10
Male1
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Time Restricted Eating
American Indian or Alaska Native0
Asian2
Native Hawaiian or Other Pacific Islander0
Black or African American0
White9
More than one race0
Unknown or Not Reported0
Age, Continuous
Age, Continuous(Years)Time Restricted Eating
Mean53.6 ± 8.0
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Time Restricted Eating
Hispanic or Latino1
Not Hispanic or Latino10
Unknown or Not Reported0
BMI
BMI(kg/m^2)Time Restricted Eating
Mean30.3 ± 6.2
Godin Leisure-Time Exercise Questionnaire
Godin Leisure-Time Exercise Questionnaire(Participants)Time Restricted Eating
Active9
Insufficiently Active/Sedentary2
08

Study locations

1 site
  • University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73117, United States
09

References and documents

Study documents

  • Study protocol · Nov 8, 2022
  • Statistical analysis plan · Nov 8, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05488652
Lead sponsor
University of Oklahoma
Responsible party
Sponsor
First posted
Aug 4, 2022
Start date
Nov 17, 2022
Primary completion
Jan 10, 2024
Completion
Jan 10, 2024
Results posted
Aug 17, 2026
Last update
Aug 17, 2026

Study contacts

Stefano Tarantini, PhD
principal investigator · University of Oklahoma

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion